Hepatitis B virus enhancer binds and is activated by the Hepatocyte nuclear factor 3

Area of Science:

• Hepatology
• Virology
• Molecular Biology

Background:

• The hepatitis B virus (HBV) enhancer exhibits liver-specific activity crucial for virus-host tropism.
• Mechanisms underlying this liver-specific enhancer activity remain poorly understood.

Purpose of the Study:

• To investigate the role of hepatocyte nuclear factor 3 (HNF3) in the liver-specific activity of the HBV enhancer.
• To elucidate the binding characteristics and functional significance of HNF3 in HBV enhancer regulation.

Main Methods:

• Recombinant HNF3 alpha binding assays to identify binding sites on the HBV enhancer.
• Transfection studies in liver and non-liver cells to assess enhancer activity.
• In vitro transcription assays using liver and HeLa cell extracts.
• Co-transfection experiments with HNF3 alpha and beta in transfected cells.

Main Results:

• Hepatocyte nuclear factor 3 (HNF3) alpha binds the HBV enhancer at two sites with differential affinity.
• The HBV enhancer demonstrates activity exclusively in liver cells, with HNF3 binding site integrity being vital for full function.
• In vitro transcription assays confirm enhancer activity in liver extracts but not in HeLa cell extracts, which are not activated by recombinant HNF3 alpha.
• Similar results observed in transfected cells, where HNF3 alpha and beta co-transfection does not fully activate the enhancer.

Conclusions:

• HNF3 activators are necessary but insufficient for complete activation of the HBV enhancer.
• Additional liver-specific factors or coactivators are required for full HBV enhancer activity.